[go: up one dir, main page]

Ohtsuka et al., 1998 - Google Patents

Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy

Ohtsuka et al., 1998

View PDF
Document ID
501262369362180605
Author
Ohtsuka Y
Udaka K
Yamashiro Y
Yagita H
Okumura K
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

Duchenne muscular dystrophy is a lethal and common X-linked recessive disease caused by a defect in dystrophin. Normal myoblast transplantation and dystrophin gene transfer have been expected to correct the deficiency in the muscles, but their clinical application has …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48776—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form forms of ingredients not provided for by groups A61K47/48784 - A61K47/48992, e.g. cells, cell fragments, viruses, ghosts, red blood cells, viral vectors having the pharmacologically or therapeutically active agent complexed or covalently linked to, or being themselves modified by complexation or covalent linkage by a modifying agent

Similar Documents

Publication Publication Date Title
Ohtsuka et al. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy
US20210301264A1 (en) Adenovirus expressing immune cell stimulatory receptor agonist(s)
Bohne et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes
Akahori et al. Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
Grayson et al. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo
Probst et al. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells
Zhang et al. In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes
Toes et al. Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion
Prévost-Blondel et al. Crucial role of TNF-α in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo
Brehm et al. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections
CN102272153B (en) High affinity t cell receptor and use thereof
Tian et al. Prevention of type 1 diabetes by gene therapy
Rubin-Kelley et al. Antigen presentation by renal tubular epithelial cells.
Perrin et al. Dynamics of antigen presentation to transgene product-specific CD4+ T cells and of Treg induction upon hepatic AAV gene transfer
O’Reilly et al. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
Obst et al. Allo‐and self‐restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire
Swanson et al. An MHC class Ib–restricted CD8 T cell response confers antiviral immunity
Groeneveldt et al. Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy
Ohteki et al. Identification of a cross‐reactive self ligand in virus‐mediated autoimmunity
Kataoka et al. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation
Murphy et al. HLA-derived peptides as novel immunomodulatory therapeutics
de Cerio et al. Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides
Wang et al. INDUCTION OF SPECIFIC ALLOGRAFT IMMUNITY BY SOLUBLE CLASS I MHC HEAVY CHAIN PROTEIN PRODUCED IN A BACULOVIRUS EXPRESSION SYSTEM1
Liu et al. An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity
Stief et al. Oncolytic virotherapy for multiple myeloma